Selected research
Industry Research
Hydroxyurea Industry Research Report 2026
Market perspective
The global Hydroxyurea market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydroxyurea is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydroxyurea is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydroxyurea is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydroxyurea include Qilu Tianhe Pharmaceutical, Tecoland, Euticals and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydroxyurea market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydroxyurea Market by Company
Qilu Tianhe Pharmaceutical
Tecoland
Euticals
Bristol-Myers Squibb
Hydroxyurea Segment by Type
Oral
Intravenous
Hydroxyurea Segment by Application
Myeloproliferative Disease
Sickle Cell Anemia
Chronic Myelogenous Leukemia
Other
Hydroxyurea Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyurea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyurea and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyurea.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydroxyurea manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydroxyurea by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydroxyurea in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Intravenous
Applications
- Myeloproliferative Disease
- Sickle Cell Anemia
- Chronic Myelogenous Leukemia
- Other
Companies covered
- Qilu Tianhe Pharmaceutical
- Tecoland
- Euticals
- Bristol-Myers Squibb
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydroxyurea Market Size (2021-2032)
- 2.2.2 Global Hydroxyurea Sales (2021-2032)
- 2.2.3 Global Hydroxyurea Market Average Price (2021-2032)
- 2.3 Hydroxyurea by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Intravenous
- 2.4 Hydroxyurea by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Myeloproliferative Disease
- 2.4.3 Sickle Cell Anemia
- 2.4.4 Chronic Myelogenous Leukemia
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydroxyurea Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydroxyurea Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Hydroxyurea Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydroxyurea Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydroxyurea Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydroxyurea, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydroxyurea, Product Type & Application
- 3.8 Global Manufacturers of Hydroxyurea, Established Date
- 3.9 Global Hydroxyurea Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Qilu Tianhe Pharmaceutical
- 4.1.1 Qilu Tianhe Pharmaceutical Company Information
- 4.1.2 Qilu Tianhe Pharmaceutical Business Overview
- 4.1.3 Qilu Tianhe Pharmaceutical Hydroxyurea Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Qilu Tianhe Pharmaceutical Hydroxyurea Product Portfolio
- 4.1.5 Qilu Tianhe Pharmaceutical Recent Developments
- 4.2 Tecoland
- 4.2.1 Tecoland Company Information
- 4.2.2 Tecoland Business Overview
- 4.2.3 Tecoland Hydroxyurea Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tecoland Hydroxyurea Product Portfolio
- 4.2.5 Tecoland Recent Developments
- 4.3 Euticals
- 4.3.1 Euticals Company Information
- 4.3.2 Euticals Business Overview
- 4.3.3 Euticals Hydroxyurea Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Euticals Hydroxyurea Product Portfolio
- 4.3.5 Euticals Recent Developments
- 4.4 Bristol-Myers Squibb
- 4.4.1 Bristol-Myers Squibb Company Information
- 4.4.2 Bristol-Myers Squibb Business Overview
- 4.4.3 Bristol-Myers Squibb Hydroxyurea Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bristol-Myers Squibb Hydroxyurea Product Portfolio
- 4.4.5 Bristol-Myers Squibb Recent Developments
5 Global Hydroxyurea Market Scenario by Region
- 5.1 Global Hydroxyurea Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydroxyurea Sales by Region: 2021-2032
- 5.2.1 Global Hydroxyurea Sales by Region: 2021-2026
- 5.2.2 Global Hydroxyurea Sales by Region: 2027-2032
- 5.3 Global Hydroxyurea Revenue by Region: 2021-2032
- 5.3.1 Global Hydroxyurea Revenue by Region: 2021-2026
- 5.3.2 Global Hydroxyurea Revenue by Region: 2027-2032
- 5.4 North America Hydroxyurea Market Facts & Figures by Country
- 5.4.1 North America Hydroxyurea Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydroxyurea Sales by Country (2021-2032)
- 5.4.3 North America Hydroxyurea Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hydroxyurea Market Facts & Figures by Country
- 5.5.1 Europe Hydroxyurea Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydroxyurea Sales by Country (2021-2032)
- 5.5.3 Europe Hydroxyurea Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hydroxyurea Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydroxyurea Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydroxyurea Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydroxyurea Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydroxyurea Market Facts & Figures by Country
- 5.7.1 South America Hydroxyurea Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydroxyurea Sales by Country (2021-2032)
- 5.7.3 South America Hydroxyurea Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hydroxyurea Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydroxyurea Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydroxyurea Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydroxyurea Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hydroxyurea Sales by Type (2021-2032)
- 6.1.1 Global Hydroxyurea Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Hydroxyurea Sales Market Share by Type (2021-2032)
- 6.2 Global Hydroxyurea Revenue by Type (2021-2032)
- 6.2.1 Global Hydroxyurea Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydroxyurea Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydroxyurea Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydroxyurea Sales by Application (2021-2032)
- 7.1.1 Global Hydroxyurea Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Hydroxyurea Sales Market Share by Application (2021-2032)
- 7.2 Global Hydroxyurea Revenue by Application (2021-2032)
- 7.2.1 Global Hydroxyurea Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydroxyurea Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydroxyurea Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydroxyurea Value Chain Analysis
- 8.1.1 Hydroxyurea Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydroxyurea Production Mode & Process
- 8.2 Hydroxyurea Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydroxyurea Distributors
- 8.2.3 Hydroxyurea Customers
9 Global Hydroxyurea Analyzing Market Dynamics
- 9.1 Hydroxyurea Industry Trends
- 9.2 Hydroxyurea Industry Drivers
- 9.3 Hydroxyurea Industry Opportunities and Challenges
- 9.4 Hydroxyurea Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst